Patents by Inventor Daniel Michaelson

Daniel Michaelson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL ACTIVATORS OF THE LIPIDATING TRANSPORTER ATP BINDING CASSETTE PROTEIN TYPE 1 (AB-CA1) AND THERAPEUTIC USES THEREOF
    Publication number: 20230103965
    Abstract: The present invention relates to compounds that are functional activators of ATP binding cassette protein type 1 (AB-CA1), and their use for treating diseases and conditions implicating ABCA1, including Alzheimer's Disease (AD) and atherosclerosis.
    Type: Application
    Filed: February 1, 2021
    Publication date: April 6, 2023
    Inventors: Daniel MICHAELSON, Zvi MENACHEM
  • COMPOSITIONS AND METHODS SPECIFICALLY TARGETING THE APOLIPOPROTEIN E4 (APOE4) AND USES THEREOF IN APOE4 ASSOCIATED CONDITIONS
    Publication number: 20200046853
    Abstract: The invention relates to improvement and therapy of neuronal conditions involving neurodegenerative, inflammatory and vascular conditions. More specifically, the invention provides compositions and methods for specific targeted elimination of apolipoprotein E4 (apoE4), and uses thereof in the treatment and prevention of ApoE4 associated conditions.
    Type: Application
    Filed: March 29, 2018
    Publication date: February 13, 2020
    Inventors: David OFFEN, Roy RABINOWITZ, Tall BEN-ZUR, Daniel MICHAELSON
  • APOE4 ANTIBODIES FOR TREATMENT OF NEURODEGENERATIVE CONDITIONS
    Publication number: 20150118231
    Abstract: The present invention relates to methods and compositions for treating neurodegenerative conditions, such as Alzheimer's Disease, by systemic administration of specific apoE4 antibodies.
    Type: Application
    Filed: May 7, 2013
    Publication date: April 30, 2015
    Inventor: Daniel Michaelson